Creutzfeldt-Jakob disease (CJD) linked to the E200K mutation of the pr
ion protein (PrP) gene presents with a wide range of age at disease on
set. Since most patients are heterozygous for the mutation, we tested
whether differential expression of mutant versus wild-type (wt) PrP ma
y affect the age at disease onset in carriers of the mutation. We meas
ured wt and mutant PrP protein and mRNA in Epstein-Barr virus (EBV)-tr
ansformed B cells of either E200K CJD patients or healthy E200K carrie
rs. Our results suggest that while in most healthy carriers the expres
sion of wt PrP was higher than that of E200K PrP, most of the E200K CJ
D patients express equal levels of both PrP proteins. Similar results
were obtained for either PrP protein or PrP mRNA. These results sugges
t that preferential expression of PrP from the wt allele may modulate
the outbreak of the disease in carriers of prion mutations. This notio
n is consistent with the results obtained in transgenic mice carrying
a human PrP gene, which suggest that endogenous PrP protects mice from
contracting scrapie after inoculation with human CJD brain. Similar m
echanisms may prevail in other inherited diseases with variable phenot
ypes.